A Closer Look at Interstitial Lung Disease
A Closer Look at Interstitial Lung Disease
Jonathan G. Goldin, MD, PhD, FRCR
Chief of Radiology, Santa Monica-UCLA Medical Center
Division Chief of the Multi-Specialty Radiology Group and
Executive Vice Chairman, of the Department of
Radiological Sciences at David Geffen School of Medicine at UCLA
Director, Thoracic Research Imaging Laboratory,
David Geffen School of Medicine at UCLA
Los Angeles, California
Dr Jonathan Goldin is the Chief of Radiology for the Santa Monica-UCLA Medical Center and Division Chief of the Multi-Specialty Radiology Group for the Department of Radiological Sciences at UCLA. He is also the Executive Vice Chairman for the Department of Radiology and the Director of the Thoracic Imaging and Research Laboratory. Dr Goldin also holds the title of Professor for both the Radiology Department and Medicine Department at the David Geffen School of Medicine at UCLA.
Dr Goldin trained at the University of Cape Town Medical School, South Africa, obtaining his MbChb in 1983. He completed his postdoctorate (PhD) in 1990. He then completed his postgraduate training in Diagnostic Radiology in 1994 at the St Bartholomew's Hospital in London, England, and his fellowship in Thoracic Radiology at the University of California, Los Angeles (UCLA).
Dr Goldin is a member and fellow of the Royal College of Radiologists (RCR). He is also a member of many scientific societies, including the Radiological Society of North America (RSNA); American Roentgen Ray Society (ARRS); American Board of Radiology (ABR); Society of Computed Body Tomography and Magnetic Resonance (SCBT); and the American Thoracic Society (ATS).
Dr Goldin's clinical and research interests include use of imaging in the early detection of disease, including lung cancer and coronary calcification screening, as well as the development of computer-aided systems for the characterization and quantization of diffuse lung disease and cardiovascular diseases. Dr Goldin has presented nationally and internationally and has authored over 130 peer-reviewed articles and 10 book chapters.
Imre Noth, MD
Professor of Medicine
Section of Pulmonary and Critical Care Medicine
Director, Interstitial Lung Disease Program
The University of Chicago
Dr Imre Noth received his Bachelor of Arts degree from the University of Pennsylvania. He then went on to obtain a Master's degree in Human Physiology at Georgetown University and received his M.D. from the University of Arizona College of Medicine. He completed a residency in Internal Medicine at the University of California at Davis Medical Center in Sacramento, CA. He then pursued a Pulmonary and Critical Care Fellowship at the University of Chicago, where upon completion in 1999, he joined the faculty. He rose to the rank of Professor of Medicine at the University of Chicago in 2012.
Dr Noth is a premiere translational researcher in the field of interstitial lung disease. Over the last decade and a half, he has concentrated his efforts on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis (IPF). This has allowed him to focus on the unique needs of this patient population. Dr Noth has participated—and continues to participate—as principal investigator in numerous clinical trials funded by industry and the NHLBI/NIH that focus predominantly on IPF. As the principal investigator for a U10 award, he was a member of the National Institutes of Health-sponsored IPF clinical research network and served on the executive committee for the IPFnet. He has also collaborated on other RO1 and UO1 awards.
His recent research includes studying the relationship between genetics, genomics, and outcomes in IPF, as well as in the conduct of novel clinical trials in IPF. His work in genetics resulted in an RC1 “Challenge” grant ward in Genetics. He has authored 67 peer-reviewed manuscripts and has mentored numerous trainees. In addition to authoring several book chapters on critical care medicine, Dr Noth is a reviewer for the American Journal of Respiratory and Critical Care Medicine and the Journal of Respiratory Diseases. He also sits on the editorial board for Chest.
Through the ILD program he hopes to continue to conduct research that will promote a better understanding of the natural history of interstitial lung diseases and develop better approaches to therapy.